在治疗新生儿发作发作时,应考虑治疗的考虑因素
Jordan Burdine1, Amanda Capino2, Mandy Harlow3
1Pharmacy Department (JB), Memorial Hermann Health System, Houston, TX.
概括
新生儿发作需要专门的治疗指导方针,由于独特的原因,如心室内出血和缺氧性缺血性脑病变. 本文回顾了用于治疗新生儿发作的药理干预措施,以改善神经发育结果.
科学领域:
- 新生儿神经学 新生儿神经学
- 儿科药理学 儿科药理学
背景情况:
- 与儿科患者相比,新生儿的发作风险更高.
- 新生儿的发作通常是由诸如早产婴儿的腹腔内出血 (IVH) 和晚产婴儿的缺氧性缺血性脑病 (HIE) 等疾病引起的.
- 早期识别和治疗对于最佳的神经发育结果至关重要.
研究的目的:
- 专注于新生儿发作的药理干预措施.
- 为这个特定人群提供治疗考虑的概述.
主要方法:
- 对新生儿发作临床实践指南的审查.
- 分析常见病因及其对治疗的影响.
- 在新生儿发作管理中使用的药理学药物的讨论.
主要成果:
- 新生儿发作与儿科发作不同,需要单独的治疗方案.
- IVH和HIE分别是导致早产和早产新生儿发作的主要原因.
- 药物治疗是管理新生儿发作的关键组成部分.
结论:
- 药理干预对于管理新生儿发作至关重要.
- 由于新生儿独特的病理生理学,需要量身定制的治疗策略.
- 新生儿发作的有效管理旨在缓解长期的神经发育缺陷.
相关概念视频
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: Sodium Channel Blockers
1.5K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.5K
Antiepileptic Drugs: Glutamate Antagonists
857
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
857
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
790
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
790


